|
[1]
|
SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy
Obesity Facts,
2019
DOI:10.1159/000499717
|
|
|
|
|
[2]
|
Characterization of SCCA-IgM as a biomarker of liver disease in an Asian cohort of patients
Scandinavian Journal of Clinical and Laboratory Investigation,
2018
DOI:10.1080/00365513.2018.1432072
|
|
|
|
|
[3]
|
Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis
Liver International,
2018
DOI:10.1111/liv.13867
|
|
|
|
|
[4]
|
Biomarkers development for early detection of cancer: Reducing the burden of cancer in the ageing society
The EuroBiotech Journal,
2018
DOI:10.2478/ebtj-2018-0005
|
|
|
|
|
[5]
|
Biomarkers development for early detection of cancer: Reducing the burden of cancer in the ageing society
The EuroBiotech Journal,
2018
DOI:10.2478/ebtj-2018-0005
|
|
|
|
|
[6]
|
Biomarkers development for early detection of cancer: Reducing the burden of cancer in the ageing society
The EuroBiotech Journal,
2018
DOI:10.2478/ebtj-2018-0005
|
|
|
|
|
[7]
|
Biomarkers in Liver Disease
Biomarkers in Disease: Methods, Discoveries and Applications,
2017
DOI:10.1007/978-94-007-7675-3_15
|
|
|
|
|
[8]
|
Circulating SCCA–IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients
Scandinavian Journal of Clinical and Laboratory Investigation,
2017
DOI:10.1080/00365513.2017.1336569
|
|
|
|
|
[9]
|
Biomarkers in Liver Disease
Biomarkers in Disease: Methods, Discoveries and Applications,
2016
DOI:10.1007/978-94-007-7742-2_15-1
|
|
|
|
|
[10]
|
Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study
Digestive and Liver Disease,
2016
DOI:10.1016/j.dld.2015.10.022
|
|
|
|
|
[11]
|
HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients
Journal of Viral Hepatitis,
2015
DOI:10.1111/jvh.12394
|
|
|
|
|
[12]
|
Analytical validation of a Biochip prototype for integrated analysis of AFP-IgM and SCCA-IgM serum biomarkers in patients with liver cirrhosis and hepatocellular carcinoma
Anal. Methods,
2015
DOI:10.1039/C4AY02495H
|
|
|
|
|
[13]
|
Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?
Clinica Chimica Acta,
2015
DOI:10.1016/j.cca.2015.03.031
|
|
|
|
|
[14]
|
Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis C
World Journal of Hepatology,
2015
DOI:10.4254/wjh.v7.i29.2913
|
|
|
|
|
[15]
|
New biomarkers for clinical management of hepatitis C virus infected patients
World Journal of Clinical Infectious Diseases,
2015
DOI:10.5495/wjcid.v5.i4.59
|
|
|
|
|
[16]
|
Specificity of squamous cell carcinoma antigen (SCCA)-IgM detection in patients with HCV infection and rheumatoid factor seropositivity
Journal of Medical Virology,
2013
DOI:10.1002/jmv.23493
|
|
|
|